Vivos Therapeutics
VVOS
VVOS
30 hedge funds and large institutions have $2.39M invested in Vivos Therapeutics in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Holders
30
Holding in Top 10
–
Calls
$7K
Puts
–
Top Buyers
| 1 | +$13.9K | |
| 2 | +$5.36K | |
| 3 | +$4.85K | |
| 4 |
VF
Virtu Financial
New York
|
+$1.89K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$402 |
Top Sellers
| 1 | -$68.8K | |
| 2 | -$21.7K | |
| 3 | -$18.1K | |
| 4 |
Two Sigma Investments
New York
|
-$10.9K |
| 5 |
Millennium Management
New York
|
-$7K |